Overview of Sildenafil Citrate Research Compound
Caverta 50mg by Ranbaxy is a sildenafil citrate formulation extensively researched for its phosphodiesterase type-5 (PDE5) enzyme inhibition properties. This research chemical enables laboratory investigation of cyclic guanosine monophosphate (cGMP) pathway modulation and vascular smooth muscle responses. As a leading Stroid UK Shop, we provide this compound for in-vitro studies examining PDE5 selectivity and nitric oxide signalling cascades in controlled laboratory environments.
Research Applications and Mechanisms
Researchers examine Caverta’s mechanism of selective PDE5 enzyme inhibition, which prevents cGMP degradation in vascular tissue models. Laboratory studies investigate how sildenafil citrate modulates intracellular calcium levels and smooth muscle contraction pathways. The compound’s molecular interactions with PDE5 binding sites provide valuable data for understanding phosphodiesterase enzyme kinetics. Scientists studying vascular biology utilise this formulation to analyse nitric oxide-dependent signalling pathways alongside other research compounds from our sildenafil citrate collection. Research applications extend to investigating cyclic nucleotide metabolism and endothelial function in cellular models.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Compound | Sildenafil Citrate |
| Dosage per Unit | 50mg |
| Manufacturer | Ranbaxy Laboratories |
| CAS Number | 171599-83-0 |
| Molecular Formula | C₂₈H₃₈N₆O₁₁S |
| Molecular Weight | 666.70 g/mol |
| Storage Conditions | Room temperature, dry environment |
This pharmaceutical-grade formulation maintains consistent potency for reproducible research outcomes. Scientists conducting comparative studies often examine this compound alongside selective androgen receptor modulators and peptide research compounds to understand different cellular signalling pathways.
Laboratory Research Compliance
Caverta 50mg is supplied exclusively for in-vitro laboratory research and analytical testing purposes. This compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must follow institutional guidelines for handling pharmaceutical research materials and maintain appropriate safety protocols during experimental procedures. All studies should comply with relevant laboratory safety standards and regulatory requirements for research chemical handling.
